FDA Stakeholders: Shape the Future of Predictive Toxicology with FDA!
On September 12, 2018, the Food and Drug Administration (FDA) will hold a public hearing at the FDA White Oak Campus to solicit comments on FDA’s Predictive Toxicology Roadmap and its implementation. The Agency is seeking comments on how to foster the development and evaluation of emerging toxicological methods and new technologies and incorporate them into the regulatory review, as applicable. On the June 30 Federal Register notice, you will find the event information and instructions on how to submit comments (by Oct 12, 2018). Visit the FDA Website to learn more about the FDA’s Predictive Toxicology Roadmap. If you plan to provide oral comments, please contact Tracy Chen, PhD, DABT. Since on-site thumb drives cannot be used during the public hearing, slides must be submitted before the event to ensure their readiness.
Please contact Tracy Chen, PhD, DABT if you have questions.